0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2008;299(14):1639. doi:10.1001/jama.299.14.1639.
Text Size: A A A
Published online

TREATMENT OF LARGE HEPATOCELLULAR CARCINOMA

Most hepatocellular carcinomas are diagnosed at intermediate or advanced stages, and only a minority of patients with tumors larger than 3 cm benefit from curative treatments. Radiofrequency thermal ablation (RFA) has been used effectively to treat small tumors, and some studies suggest that transarterial chemoembolization (TACE) improves survival in patients with hepatocellular carcinoma. To assess whether treating patients with TACE and RFA may offer a survival benefit, Cheng and colleagues Article randomly assigned 291 patients with hepatocellular carcinomas larger than 3 cm to treatment with TACE-RFA, TACE alone, or RFA alone. During a median 28.5 months of follow-up, median survival times were 37 months in the TACE-RFA group, 24 months in the TACE-alone group, and 22 months in the RFA-alone group. In an editorial, Zhu and Abou-Alfa Article discuss expanding treatment options for hepatocellular carcinoma.

AGGRESSIVE RISK FACTOR TARGETS IN DIABETES

Persons with type 2 diabetes have an increased risk of cardiovascular disease (CVD), and some data have suggested that setting low-density lipoprotein cholesterol (LDL-C) and blood pressure targets below those currently recommended might slow or reverse CVD progression. In the Stop Atherosclerosis in Native Diabetics Study (SANDS), Native American patients with type 2 diabetes were randomly assigned to aggressive treatment targets (LDL-C ≤ 70 mg/dL and systolic blood pressure [SBP] ≤115 mm Hg) or standard treatment targets (LDL-C ≤ 100 mg/dL and SBP ≤ 130 mm Hg), and the progression of subclinical atherosclerosis was assessed. Howard and colleagues Article report that compared with standard treatment targets, aggressive treatment targets were associated with regression of carotid intimal media thickness and greater decrease in left ventricular mass during the 3-year study. In an editorial, Peterson and Wang Article discuss the evidence regarding intensive risk factor lowering and primary prevention of CVD.

OMEGA-3 FREE FATTY ACIDS AND CROHN DISEASE

An effective, safe, and inexpensive therapy to maintain remission of Crohn disease is needed. Some evidence suggests that omega-3 free fatty acids are effective in treatment of some inflammatory disorders, although evidence for a beneficial effect in patients with Crohn disease is inconsistent. Feagan and colleagues report results of 2 multicenter randomized placebo-controlled studies, EPIC-1 (Epanova Program in Crohn’s) and EPIC-2, in which patients with quiescent Crohn disease were randomly assigned to receive either 4 g of omega-3 free fatty acids or placebo for up to 58 weeks. In an analysis of data from 738 patients, the investigators found that treatment with high-dose omega-3 free fatty acids was no more effective than placebo in preventing relapse of Crohn disease over 1 year of follow-up.

CLINICIAN'S CORNER
EFFECTIVENESS OF SPECIALIZED PALLIATIVE CARE

In a systematic review of data from randomized controlled trials, Zimmermann and colleagues examined the evidence for the effectiveness of specialized palliative care to improve patients' quality of life, increase patient and family satisfaction with care, and reduce economic cost.

A PIECE OF MY MIND

“[H]ere was a 50-year-old woman with a wound that seemed so harsh and raw, cruelly robbing her of a vital piece of her external femininity.” From “Wound Healing.”

MEDICAL NEWS & PERSPECTIVES

A new online tool aims to help primary care physicians in a variety of settings better assess fracture risk in patients with low bone mass.

COMMENTARIES

Sharing interim clinical trial results

Iraqi refugee crisis

AUTHOR IN THE ROOM TELECONFERENCE

Join Laura P. Svetkey, MD, MHS, April 16, 2008, from 2 to 3 PM eastern time to discuss strategies for sustaining weight loss. To register, go to http://www.ihi.org/AuthorintheRoom.

AUDIO COMMENTARY

Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl

READERS RESPOND

How would you manage a 50-year-old man with chronic low back pain? Go to www.jama.com to read the case and submit your response. Your response may be selected for online publication. Submission deadline is April 30.

JAMA PATIENT PAGE

For your patients: Information about Crohn disease.

First Page Preview

View Large
First page PDF preview

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.